Gene therapy using gene fusion for genetic or acquired disorders
CA 1339654 C · Owner: Pastan, Ira · Inventors: Germann, Ursula A.; Pastan, Ira; Gottesman, Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is related generally to the construction of fusion genes. More particularly the, present invention is related to the construction of a fusion gene comprising a coding sequence for a selectable marker linked by fusion to another coding sequence the, product of which is desired to be expressed in recipient cells. Gene therapy utilizing an MDR1 linked fusion coding sequence has been disclosed. Adenosine deaminase activity has been introduced into cells using MDR1 linked fusion gene.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 3, 1998. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 3, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.